Company overview
TESCAN GROUP provides advanced scanning electron microscopes (SEM), focused ion beam SEM (FIB-SEM), transmission electron microscopes (TEM), and micro-CT systems for life sciences and pharmaceutical R&D. These instruments support high-resolution imaging, 3D analysis, and material characterization in biological and pharmaceutical research applications. With installations worldwide, TESCAN enables non-destructive internal analysis and dynamic imaging for drug development and biomaterial studies.
Accelerating the Art of Discovery is listed in the NovaPharmaNews Supplier Hub as a CRO & Clinical Services partner serving United States & Americas. Core focus areas include tescan group, scanning electron microscope, fib-sem, micro-ct, life sciences microscopy, pharma imaging.
Industry categories: CRO & Clinical Services. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Products and technologies associated with Accelerating the Art of Discovery include Cro — relevant for pharmaceutical discovery, process development, and GMP manufacturing workflows.
Structured facts
- Website
- https://tescan.com
- Categories
- CRO & Clinical Services
- Markets served
- United States & Americas
- Keywords
- tescan group, scanning electron microscope, fib-sem, micro-ct, life sciences microscopy, pharma imaging
Products & technologies
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What imaging capabilities does TESCAN offer for life sciences R&D?
- TESCAN offers SEM, FIB-SEM, TEM including 4D-STEM like TESCAN TENSOR, and micro-CT systems for high-resolution 3D/4D imaging in life sciences, supporting biological sample analysis and material characterization.
- What are TESCAN's global service and installation footprints?
- Headquartered in Brno, Czech Republic, TESCAN has approximately 3,000 installations worldwide, with expansion plans including a new subsidiary in Taiwan in 2025 to serve Asia-Pacific semiconductor and research clients.
- How do TESCAN systems support pharmaceutical and biotech applications?
- TESCAN's electron microscopy and micro-CT solutions enable non-destructive analysis, dynamic in-situ imaging, and advanced workflows for pharmaceuticals, including battery materials, biomaterials, and geoscience-related life science research.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
